MedPath
HSA Approval

NOVATRETIN CAPSULE 25MG

SIN15270P

NOVATRETIN CAPSULE 25MG

NOVATRETIN CAPSULE 25MG

June 13, 2017

APEX PHARMA MARKETING PTE. LTD.

APEX PHARMA MARKETING PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantAPEX PHARMA MARKETING PTE. LTD.
Licence HolderAPEX PHARMA MARKETING PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

CAPSULE

ORAL

Medical Information

D05BB02

acitretin

Manufacturer Information

APEX PHARMA MARKETING PTE. LTD.

Micro-Sphere SA

Douglas Manufacturing Ltd. (Primary and Secondary Packager)

Active Ingredients

Acitretin

25.0mg

Acitretin

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

NOVATRETIN CAPSULE 25MG - HSA Approval | MedPath